Multicenter study of urinary migrasomes as a diagnostic biomarker of chronic kidney disease

urinary migrasomes serve as a diagnostic biomarker of chronic kidney disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058801

Enrollment

Unknown

Registered

2022-04-17

Start date

2022-04-20

Completion date

Unknown

Last updated

2023-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Gold Standard:renopuncture

Index test:urine migrasome

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-85 years; 2) complete test results of blood creatinine, urinary creatinine and urinary microalbumin; 3) Did not receive any CKD associated therapy; 4) CKD can be confirmed by renopuncture; 5) Be willing to provide urine samples for this clinical study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Did not receive any CKD associated therapy; 2) Clinically definite active infection; 3) Subjects who cannot obtain the urine sample due to unqualified quality inspection of samples; 4) Female subjects during pregnancy or lactation; 5) Other researchers think it is not suitable to be included in the group.

Design outcomes

Primary

Measure	Time frame
migrasome;	—

Countries

china

Contacts

Public Contacthongwei liang

China Pharmaceutical University

hwliang@cpu.edu.cn19822621160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026